• Drop us a line for any questions: info@assayvector.com

Ikaros Rabbit pAb

Cat No.: APA1271
Size:
Product Name: Ikaros Rabbit pAb
Cat No.: APA1271
source: Rabbit
reactivity: Human, Mouse, Rat
applications: WB,IHC,FC
clonality: Polyclonal
recommended dilution: WB: 1:2000
IHC: 1:200
FC: 1:20
format: Liquid
isotype: IgG
immunogen: A synthetic peptide of human Ikaros
calculated molecular weight: 58 kDa
observed molecular weight: 50-70 kDa
genbank accession number: Q13422
gene id (ncbi): 10320
purification method: Affinity Purification
conjugate: Un-conjugated
storage: Store at -20°C. Supplied in 50nM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% sodium azide and 0.05% BSA. Stable for 12 months from date of receipt.
synonyms: IK1; LYF1; LyF-1; CVID13; IKAROS; PPP1R92; PRO0758; ZNFN1A1; Hs.54452
category: Primary Ab
concentration: 0.5mg/ml
background: This gene encodes a transcription factor that belongs to the family of zinc-finger DNA-binding proteins associated with chromatin remodeling. The expression of this protein is restricted to the fetal and adult hemo-lymphopoietic system, and it functions as a regulator of lymphocyte differentiation. Several alternatively spliced transcript variants encoding different isoforms have been described for this gene. Most isoforms share a common C-terminal domain, which contains two zinc finger motifs that are required for hetero- or homo-dimerization, and for interactions with other proteins. The isoforms, however, differ in the number of N-terminal zinc finger motifs that bind DNA and in nuclear localization signal presence, resulting in members with and without DNA-binding properties. Only a few isoforms contain the requisite three or more N-terminal zinc motifs that confer high affinity binding to a specific core DNA sequence element in the promoters of target genes. The non-DNA-binding isoforms are largely found in the cytoplasm, and are thought to function as dominant-negative factors. Overexpression of some dominant-negative isoforms have been associated with B-cell malignancies, such as acute lymphoblastic leukemia (ALL). [provided by RefSeq, May 2014]